Inogen | INGN - Stock


Inogen reported $25.08M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Accuray USD 155.5M 14.48M Sep/2025
AngioDynamics USD 65.57M 3.56M Sep/2025
Artivion USD 92.43M 1.88M Dec/2025
AtriCure USD 81.14M 2.65M Mar/2026
Baxter International USD 2.32B 84M Mar/2026
Becton, Dickinson and Co. USD 4.08B 191M Dec/2025
Boston Scientific USD 3.12B 174M Mar/2026
Chart Industries USD 572.3M 58.1M Dec/2025
Cooper Companies USD 846M 35M Sep/2025
Dexcom USD 693.6M 64.5M Mar/2026
Edwards Lifesciences USD 1.13B 14.7M Dec/2025
Globus Medical USD 759.28M 12.26M Dec/2025
Inogen USD 25.08M 762K Sep/2025
Insulet USD 452.6M 6.3M Dec/2025
Masimo USD 338.6M 20.1M Sep/2025
Medtronic USD 6.31B 153M Dec/2025
Orthofix International USD 177.82M 5.5M Mar/2026
Philips EUR 3.26B 28M Sep/2025
ResMed USD 911.88M 10.17M Mar/2026
Steris USD 673.5M 15M Dec/2025
Stryker USD 5.42B 109M Mar/2026
Tandem Diabetes Care USD 128.77M 8.51M Dec/2025
Teleflex USD 802.46M 108.78M Sep/2025
Zimmer Biomet Holdings USD 2.25B 39.6M Mar/2026